AlphaYouFF
Insider buying
Fairmount Funds Management Llc bought $12.4M of Crescent Biopharma, Inc. (CBIO) stock
Fairmount Funds Management Llc, Dir, 10% of Crescent Biopharma, Inc. (CBIO), bought 853,450 shares of CBIO stock worth $12.4M, per an SEC Form 4 filed Jul 20, 2026.
It was an open-market purchase.
The trade happened on Jul 16, 2026, 4 days before it was made public.
CBIO has moved +7.5% since the trade date, from $15.11 to $16.25 (Sep 21, 2026 close).
- Traded
- Jul 16, 2026
- Disclosed
- Jul 20, 2026
- Filing delay
- 4 days
- Price since
- +7.5%
- Role
- Dir, 10%
- Source
- SEC Form 4
More CBIO insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.